Synapse - Neeta Pandit-Taskar

Results (15)

PET imaging of breast cancer: Role in patient management

Journal Article

Lebron, L.; Greenspan, D.; Pandit-Taskar, N.
PET Clinics (2015)

Final results of a randomized phase 1b study of fractionated 90Y-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having at least two prior therapies

Meeting Abstract

Picozzi, V. J.; Ramanathan, R. K.; Lowery, M. A.; Ocean, A. J.; Mitchell, E. P.; O'Neil, B. H.; Guarino, M. J.; Conkling, P. R.; Cohen, S. J.; Bahary, N.; more...
Cancer Research (2015)

Fulltext@MSK | Save

A phase I/II study for analytic validation of 89Zr-J591 immunoPET as a molecular imaging agent for metastatic prostate cancer

Journal Article

Pandit-Taskar, N.; O'Donoghue, J. A.; Durack, J. C.; Lyashchenko, S. K.; Cheal, S. M.; Beylergil, V.; Lefkowitz, R. A.; Carrasquillo, J. A.; Martinez, D. F.; Fung, A. M.; more...
Clinical Cancer Research (2015)

Fulltext@MSK | Save

Radioembolization as a salvage therapy for heavily pretreated patients with colorectal cancer liver metastases: Factors that affect outcomes

Journal Article

Sofocleous, C. T.; Violari, E. G.; Sotirchos, V. S.; Shady, W.; Gonen, M.; Pandit-Taskar, N.; Petre, E. N.; Brody, L. A.; Alago, W.; Do, R. K.; more...
Clinical Colorectal Cancer (2015)

Fulltext@MSK | Save

PET-based compartmental modeling of (124)I-A33 antibody: Quantitative characterization of patient-specific tumor targeting in colorectal cancer

Journal Article

Zanzonico, P.; Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Smith-Jones, P.; Ruan, S.; Divgi, C.; Scott, A. M.; Kemeny, N. E.; more...
European Journal of Nuclear Medicine and Molecular Imaging (2015)

Fulltext@MSK | Save

First in human (89)Zr-Df-IAB2M antiprostate specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer

Meeting Abstract

Pandit-Taskar, N.; O'Donoghue, J.; Martinez, D.; Lyashchenko, S.; Carrasquillo, J.; Durack, J.; Keppler, J.; Scher, H.; Larson, S.; Morris, M.
Journal of Nuclear Medicine (2015)

Fulltext@MSK | Save

Wholebody clearance of three (89)Zr labeled antibodies: Differences between PET based and whole body probe based clearance

Meeting Abstract

Beylergil, V.; Pandit-Taskar, N.; Larson, S.; Morris, M.; Danila, D. C.; Bander, N.; Fine, B.; Carrasquillo, J.; Weber, W.; O'Donoghue, J.
Journal of Nuclear Medicine (2015)

Fulltext@MSK | Save

Effects of radium-223 dichloride (Ra-223) with docetaxel (D) vs D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial

Meeting Abstract

Morris, M. J.; Higano, C. S.; Scher, H. I.; Sweeney, C.; Antonarakis, E. S.; Shevrin, D. H.; Ryan, C. J.; Loriot, Y.; Fizazi, K.; Pandit-Taskar, N.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591

Meeting Abstract

Feldman, J. L.; Morris, M. J.; Martinez, D. F.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies

Journal Article

Picozzi, V. J.; Ramanathan, R. K.; Lowery, M. A.; Ocean, A. J.; Mitchel, E. P.; O'Neil, B. H.; Guarino, M. J.; Conkling, P. R.; Cohen, S. J.; Bahary, N.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save